by Administrators Qynapse | Nov 22, 2021 | News
BOSTON, MA, November 22, 2021, PRNewswire – Qynapse Inc., a medical technology company commercializing an artificial intelligence (AI)-powered neuroimaging software platform for central nervous system (CNS) disorders, will unveil its new brand and latest AI...
by Administrators Qynapse | Nov 4, 2021 | News
BOSTON, MA, November 4, 2021, PRNewswire – Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders, is pleased to sponsor the 14th Clinical Trials on Alzheimer’s Disease...
by Administrators Qynapse | Oct 21, 2021 | News
BOSTON, MA, October 21, 2021, PRNewswire – Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders, announced today the appointment of Adam J. Schwarz, Ph.D., as Chief...
by Administrators Qynapse | Sep 19, 2021 | News
BOSTON, MA, September 20, 2021, PRNewswire – Qynapse Inc., a medical technology company commercializing an AI-powered neuroimaging software platform for central nervous system (CNS) disorders, unveils a full rebrand including new logo and a complete website redesign,...
by Administrators Qynapse | Aug 26, 2021 | News
BOSTON, MA, July 26, 2021 /PRNewswire/ – QYNAPSE Inc., a medical technology company commercializing an AI-powered and proprietary neuroimaging software platform, is attending the Alzheimer’s Association International Conference 2021 (AAIC) on July 26-30, 2021 in...
by Administrators Qynapse | Jun 15, 2021 | News
BOSTON, MA, May 30, 2021 /PRNewswire/ – QYNAPSE Inc., a medical technology company commercializing the most advanced artificial intelligence neuroimaging platform, today announced it will present clinical data on QyScore® for Alzheimer’s disease and multiple sclerosis...